# Linking Cortical Morphometry in Self‐Limited Epilepsy With Centrotemporal Spikes to Cognition, Function, and Molecular Architecture

**Authors:** Siqi Yang, Jie Xia, Wei Liao, Yimin Zhou, Chengzong Peng, Juan Wang, Zhiqiang Zhang

PMC · DOI: 10.1002/cns.70794 · CNS Neuroscience & Therapeutics · 2026-02-23

## TL;DR

This study explores how brain structure changes in a common childhood epilepsy are linked to cognitive and molecular factors, offering new insights into the condition's complexity.

## Contribution

A novel framework linking structural brain deviations to clinical and molecular profiles in pediatric epilepsy.

## Key findings

- Eight biologically interpretable brain structural deviation patterns were identified in SeLECTS.
- These deviations are associated with cognitive control, language, and mitochondrial function.
- Factors like age and medication history influence morphological development in key brain regions.

## Abstract

Self‐limiting epilepsy with centrotemporal spikes (SeLECTS) is the most common type of pediatric epilepsy, characterized by age‐dependent seizures, which usually occur during the development of a child's brain. This condition is associated with heterogeneous neurodevelopmental alterations, including cortical thinning, changes in subcortical structures, and atypical development linked to the disease.

To establish an integrative model of neurodevelopment in SeLECTS, we investigated how its structural brain alterations are linked to clinical phenotypes, aberrant brain network function, and the local molecular architecture. Using normative modeling, we analyzed magnetic resonance imaging (MRI)‐derived morphometric features, specifically cortical thickness and subcortical volumes, in a multicenter preschool cohort (devCCNP, n = 457) and a SeLECTS cohort (n = 187) and generated deviation matrices specific to SeLECTS.

Nonnegative matrix factorization was applied to decompose these matrices into eight deviation components, revealing biologically interpretable patterns of heterogeneity, along with subject‐specific loadings that quantify the expression of these components in individual subjects. Behavioral partial least squares analysis identified significant associations between subject‐specific loadings and phenotypic profiles in SeLECTS, suggesting that factors such as age, medication history, and disease duration are important for morphological development—particularly in temporal and frontal regions associated with cognitive control and language. Furthermore, we explored the molecular basis of the morphometric deviation components by mapping their spatial expression to features related to functional cognition, neurotransmitter/transcript profiles, and mitochondrial characteristics.

Collectively, this study provides a novel framework for elucidating the neuroanatomical heterogeneity of epilepsy, offering insights into its behavioral and molecular correlates.

This study provides a novel framework modeling neurodevelopment in self‐limited epilepsy with centrotemporal spikes. We identify eight biologically interpretable brain structural deviation patterns, which are linked to clinical phenotypes and molecular profiles involving cognition and mitochondrial function. This integration elucidates multidimensional brain‐behavior‐molecular correlates in pediatric epilepsy.

## Linked entities

- **Diseases:** epilepsy (MONDO:0005027)

## Full-text entities

- **Genes:** HTR2A (5-hydroxytryptamine receptor 2A) [NCBI Gene 3356] {aka 5-HT2A, HTR2}, SLC6A3 (solute carrier family 6 member 3) [NCBI Gene 6531] {aka DAT, DAT1, PKDYS, PKDYS1}, CNR1 (cannabinoid receptor 1) [NCBI Gene 1268] {aka CANN6, CB-R, CB1, CB1A, CB1K5, CB1R}, HTR1A (5-hydroxytryptamine receptor 1A) [NCBI Gene 3350] {aka 5-HT-1A, 5-HT1A, 5HT1a, ADRB2RL1, ADRBRL1, G-21}, HTR4 (5-hydroxytryptamine receptor 4) [NCBI Gene 3360] {aka 5-HT4, 5-HT4R}, HTR6 (5-hydroxytryptamine receptor 6) [NCBI Gene 3362] {aka 5-HT6, 5-HT6R}, SLC6A4 (solute carrier family 6 member 4) [NCBI Gene 6532] {aka 5-HTT, 5-HTTLPR, 5HTT, HTT, OCD1, SERT}, GRM5 (glutamate metabotropic receptor 5) [NCBI Gene 2915] {aka GPRC1E, MGLUR5, PPP1R86, mGlu5}, HTR1B (5-hydroxytryptamine receptor 1B) [NCBI Gene 3351] {aka 5-HT-1B, 5-HT-1D-beta, 5-HT1B, 5-HT1DB, HTR1D2, HTR1DB}, OPRM1 (opioid receptor mu 1) [NCBI Gene 4988] {aka LMOR, M-OR-1, MOP, MOR, MOR1, OPRM}, SLC18A3 (solute carrier family 18 member A3) [NCBI Gene 6572] {aka CMS21, VACHT}, CS (citrate synthase) [NCBI Gene 1431]
- **Diseases:** attention deficit hyperactivity disorder (MESH:D001289), epilepsy syndrome (MESH:D000073376), brain damage (MESH:D001925), NMF (MESH:C535501), Epilepsy (MESH:D004827), hippocampal sclerosis (MESH:D000092223), cognitive deficits (MESH:D003072), brain tumors (MESH:D001932), cortical dysplasia (MESH:D054220), epileptiform (MESH:D014277), cavernous malformations (MESH:D020786), neurological or psychiatric disorders (MESH:D001523), Epilepsy With Centrotemporal Spikes (MESH:D019305), pain (MESH:D010146), Mitochondrial dysfunction (MESH:D028361), LV (MESH:D000085343), neurological disorder (MESH:D009461), seizure (MESH:D012640), hyperactivity (MESH:D006948), vascular malformations (MESH:D054079), stroke (MESH:D020521)
- **Chemicals:** GABA (-), serotonin (MESH:D012701), dopamine (MESH:D004298), endocannabinoid (MESH:D063388), norepinephrine (MESH:D009638), glutamate (MESH:D018698)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12928023/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12928023/full.md

## References

45 references — full list in the complete paper: https://tomesphere.com/paper/PMC12928023/full.md

---
Source: https://tomesphere.com/paper/PMC12928023